PMID: 6112564Jun 6, 1981Paper

Trial of heparin versus atenolol in prevention of myocardial infarction in intermediate coronary syndrome

Lancet
A M Telford, C Wilson

Abstract

A randomised, double-blind, placebo controlled study of morbidity and mortality was carried out using heparin, atenolol, and a combination of both drugs, in 214 patients with the intermediate coronary syndrome. During the trial period, transmural myocardial infarction developed in 9 (17%) out of 54 patients on placebo, 8 (13%) out of 60 on atenolol, 1 (2%) out of 51 on heparin, and 2 (4%) out of 49 on heparin and atenolol combined (p = 0.024). The improved prognosis in the heparin-treated patients was was maintained at follow-up. All five deaths occurred among patients who did not receive heparin. These results show that intravenous heparin therapy was of benefit in preventing myocardial infarction in patients with the intermediate coronary syndrome.

References

Dec 1, 1975·Circulation·A A AlonzoM Feinleib
May 1, 1972·Circulation·K R KraussR W DeSanctis
Nov 1, 1970·British Heart Journal·M Stowers, D Short
Oct 1, 1969·Circulation·H A SolomonT Killip
Oct 1, 1969·Circulation·S Wolfson, R Gorlin
Jun 24, 1961·British Medical Journal·P WOOD

❮ Previous
Next ❯

Citations

Jul 1, 1992·Journal of Clinical Pharmacology·M D Freedman
May 1, 1988·Cardiovascular Drugs and Therapy·H D Lewis
Sep 1, 1988·Cardiovascular Drugs and Therapy·C W Hamm, W Bleifeld
Jan 1, 1991·European Journal of Clinical Pharmacology·M DellborgK Swedberg
Jan 1, 1988·Intensive Care Medicine·H E DemeyL L Bossaert
Jan 1, 1990·European Journal of Clinical Pharmacology·W Bleifeld
Dec 1, 1989·Cardiovascular Drugs and Therapy·B Stein, V Fuster
Mar 1, 1988·Cardiovascular Drugs and Therapy·P J Commerford
Aug 18, 2010·Cardiovascular Drugs and Therapy·Nicolas Danchin, Nadia Aïssaoui
Nov 30, 2000·Current Treatment Options in Cardiovascular Medicine·M B Murad, T D Henry
Oct 23, 2012·Current Treatment Options in Cardiovascular Medicine·Charles V Pollack
Oct 20, 1986·The American Journal of Medicine·S O Gottlieb, G Gerstenblith
Feb 23, 1991·Lancet·A G Violaris, S Campbell
Aug 1, 1988·Journal of the American College of Cardiology·C de ZwaanH J Wellens
Dec 1, 1988·Journal of the American College of Cardiology·H SuryapranataP W Serruys
Sep 1, 1989·Journal of the American College of Cardiology·R L WilenskyM Tulchinsky
Oct 1, 1989·Journal of the American College of Cardiology·B SteinJ H Chesebro
Oct 1, 1991·Journal of the American College of Cardiology·P R EisenbergA S Jaffe
Apr 1, 1993·Journal of the American College of Cardiology·J T Willerson, W Casscells
Sep 1, 1995·Journal of the American College of Cardiology·T L SchreiberW W O'Neill
Aug 1, 1995·Journal of the American College of Cardiology·E P GurfinkelB Mautner
Sep 20, 1997·The American Journal of Cardiology·A G Turpie
Dec 24, 1997·Progress in Cardiovascular Diseases·A E Schussheim, V Fuster
Sep 18, 1999·Thrombosis Research·R GalloJ J Badimon
May 18, 1999·International Journal of Cardiology·M FerrarioD Ardissino
Jun 1, 1985·Journal of the American College of Cardiology·V FusterJ H Chesebro
Dec 1, 1986·Journal of the American College of Cardiology·C E Hjemdahl-MonsenV Fuster
Oct 1, 1987·Journal of the American College of Cardiology·S O GottliebG Gerstenblith
Nov 1, 1987·Journal of the American College of Cardiology·C W HammP C Weber
Nov 1, 1987·Journal of the American College of Cardiology·H K GoldD Collen
Apr 30, 1998·Journal of the American College of Cardiology·H M KrumholzM J Radford
Nov 6, 1998·British Journal of Clinical Pharmacology·R P Steeds, K S Channer
Oct 9, 1986·The New England Journal of Medicine·C T ShermanL Morgenstern
Jul 16, 1992·The New England Journal of Medicine·P ThérouxJ McCans
Jan 13, 2000·The New England Journal of Medicine·Y YeghiazariansP H Stone

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.